Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Genomic Research Center, |
RCV000785103 | SCV000923661 | uncertain significance | PLIN1-related familial partial lipodystrophy | 2019-01-01 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000969373 | SCV001116886 | likely benign | not provided | 2019-12-31 | criteria provided, single submitter | clinical testing | |
Personalized Diabetes Medicine Program, |
RCV001174448 | SCV001337587 | likely benign | Monogenic diabetes | 2018-04-09 | criteria provided, single submitter | research | ACMG criteria: PP3 (2 predictors), BP4 (7 predictors), REVEL 0.058, BS2 (15 cases and 13 controls in type2diabetesgenetics.org)=likely benign |
Ce |
RCV000969373 | SCV005435786 | likely benign | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | PLIN1: BP4, BS2 |
Genetic Services Laboratory, |
RCV003151147 | SCV003839880 | likely benign | not specified | 2022-08-08 | no assertion criteria provided | clinical testing | |
Prevention |
RCV003918264 | SCV004735697 | likely benign | PLIN1-related disorder | 2019-06-13 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |